A 43-year-old man presents with continuous vomiting and abdominal guarding on palpation, raising suspicion for acute cholecystitis. Which of the following investigations can exclude acute cholecystitis in this patient?
What is true about the Pringle maneuver?
Strasberg's Class B bile duct injury means:
Which of the following is NOT included in Charcot's triad?
Which of the following is NOT a risk factor for cholangiocarcinoma?
Which of the following statements about hydatid cyst of the liver is FALSE?
What is the best screening method for Mirizzi syndrome?
What is true about choledochal cysts?
Which of the following is not considered a precancerous lesion of the gallbladder?
Which of the following statements about gallstones is false?
Explanation: **Explanation:** The diagnosis of acute cholecystitis is primarily clinical, supported by imaging. The correct answer is **Radionuclide imaging (HIDA scan)** because of its exceptionally high **negative predictive value (NPV)**. **1. Why Radionuclide Imaging is Correct:** HIDA (Hepatobiliary Iminodiacetic Acid) scan is considered the **gold standard** for diagnosing acute cholecystitis. The underlying mechanism involves the intravenous injection of a radioactive tracer that is excreted by the liver into the bile. In a healthy individual, the tracer fills the gallbladder. In acute cholecystitis, the cystic duct is obstructed (usually by a stone). Therefore, if the gallbladder is **visualized** within 60 minutes, the patency of the cystic duct is confirmed, effectively **excluding** acute cholecystitis. **2. Why Other Options are Incorrect:** * **Ultrasound (A):** While it is the **initial investigation of choice** due to its availability and ability to show gallstones, wall thickening, and pericholecystic fluid, it cannot definitively exclude the diagnosis as it is operator-dependent and may miss functional obstruction. * **ERCP (B):** This is an invasive procedure used primarily for managing choledocholithiasis (CBD stones) or biliary obstruction. It is not a diagnostic tool for acute cholecystitis. * **OCG (C):** Oral Cholecystography is an obsolete investigation. It requires a functioning gallbladder to concentrate dye over 24-48 hours, making it useless in an acute setting. **Clinical Pearls for NEET-PG:** * **Initial Investigation of Choice:** Ultrasonography (Look for "Murphy’s Sign" on USG). * **Most Sensitive/Gold Standard:** HIDA Scan (Radionuclide imaging). * **Diagnostic Hallmark on HIDA:** Non-visualization of the gallbladder despite visualization of the CBD and duodenum. * **False Positives in HIDA:** Can occur in prolonged fasting, total parenteral nutrition (TPN), or severe liver disease.
Explanation: ### Explanation The **Pringle maneuver** is a surgical technique used to minimize blood loss during hepatic surgery or trauma by occluding the **portal triad** (the hepatoduodenal ligament). **Why Option C is Correct:** The Pringle maneuver is synonymous with **total inflow occlusion**. By applying a non-crushing vascular clamp (or a Rummel tourniquet) across the foramen of Winslow, the surgeon halts all blood entering the liver via the **portal vein** and the **hepatic artery**. This creates a bloodless field for parenchymal transection or repair. **Why Other Options are Incorrect:** * **Option A:** While the clamp is placed at the foramen of Winslow, it only occludes the portal triad. It **does not occlude the Inferior Vena Cava (IVC)**, which lies posterior to the foramen. * **Option B:** The maneuver controls bleeding from the portal vein and hepatic artery (inflow). It **cannot control bleeding from the IVC or the hepatic veins** (outflow). If bleeding persists despite a Pringle maneuver, it indicates a retrohepatic IVC injury or hepatic vein involvement. * **Option D:** Since A and B are anatomically incorrect, "All of the above" is false. **High-Yield Clinical Pearls for NEET-PG:** * **Maximum Duration:** Usually limited to **60 minutes** for a healthy liver and **30 minutes** for a cirrhotic liver to prevent warm ischemia-reperfusion injury. * **Intermittent Pringle:** Often preferred (e.g., 15 mins occlusion followed by 5 mins reperfusion) to extend the safe operative window. * **Persistent Bleeding:** If bleeding continues during the maneuver, consider an **aberrant left hepatic artery** (arising from the left gastric artery) or injury to the **hepatic veins/IVC**. * **Total Vascular Exclusion (TVE):** This involves a Pringle maneuver *plus* clamping the IVC (supra- and infra-hepatic) to control both inflow and outflow.
Explanation: ### Explanation The **Strasberg Classification** is a widely used system to categorize laparoscopic bile duct injuries, expanding upon the earlier Bismuth classification. **1. Why the Correct Answer is Right:** **Option B** is correct because **Strasberg Type B** refers to the **occlusion** (usually by clipping or ligation) of an aberrant or sectoral bile duct, most commonly the **right sectoral duct**. Because the duct is occluded and not leaking, it often presents late with segmental cholestasis or atrophy of that specific liver segment, rather than acute peritonitis. **2. Analysis of Incorrect Options:** * **Option A (Type A):** This involves a **bile leak** from a minor duct (like the cystic duct or a small duct in the liver bed) that remains in communication with the common bile duct. * **Option C (Type C):** This involves a **transection without ligation** of an aberrant/sectoral duct. Unlike Type B, this duct is *not* in communication with the common bile duct, leading to a persistent bile leak. * **Option D (Type E):** Circumferential injuries or strictures of the **major bile ducts** (Common Hepatic Duct/Common Bile Duct) are classified as **Type E (E1 to E5)**, which is essentially the Bismuth classification. **3. Clinical Pearls for NEET-PG:** * **Type A** is the most common type of injury post-laparoscopic cholecystectomy. * **Type D** refers to a lateral (partial) injury to the major bile ducts. * **Mnemonic for Strasberg A-D:** * **A:** **A**llows leak (minor duct). * **B:** **B**locked (occluded sectoral duct). * **C:** **C**ut (transected sectoral duct, leaking). * **D:** **D**amaged wall (lateral injury to major duct). * **Management:** Type A is usually managed by ERCP and stenting; Type E often requires surgical reconstruction (Roux-en-Y Hepaticojejunostomy).
Explanation: **Explanation:** **Charcot’s Triad** is the classic clinical presentation of **Acute Cholangitis**, which occurs due to biliary obstruction (most commonly by gallstones) followed by an ascending bacterial infection. The correct answer is **Gallbladder lump**, as it is not a component of this triad. 1. **Why Gallbladder lump is the correct answer:** A palpable gallbladder lump is more characteristic of **Courvoisier’s Law** (associated with periampullary carcinoma) or a **Mucocele** of the gallbladder. In acute cholangitis, the gallbladder is often shrunken or not palpable due to chronic cholecystitis, and the pathology primarily involves the common bile duct (CBD). 2. **Why the other options are incorrect:** * **Fever (A):** Present in nearly 95% of cases, often accompanied by chills and rigors due to bacteremia. * **Pain (B):** Specifically, Right Upper Quadrant (RUQ) pain caused by biliary distension and inflammation. * **Jaundice (C):** Resulting from the obstruction of bile flow into the duodenum, leading to conjugated hyperbilirubinemia. **High-Yield Clinical Pearls for NEET-PG:** * **Reynolds’ Pentad:** If Charcot’s Triad is accompanied by **Hypotension (Shock)** and **Altered Mental Status**, it is known as Reynolds’ Pentad, indicating life-threatening obstructive suppurative cholangitis. * **Management:** The gold standard for both diagnosis and therapeutic decompression in acute cholangitis is **ERCP (Endoscopic Retrograde Cholangiopancreatography)**. * **Tokyo Guidelines (TG18):** Modern diagnosis relies on these criteria, which include signs of systemic inflammation, cholestasis, and imaging evidence of biliary dilatation/etiology.
Explanation: **Explanation:** The question asks for the factor that is **NOT** a risk factor for cholangiocarcinoma. While chronic inflammation of the biliary tree is the common denominator for most risk factors, **Choledocholithiasis (Option D)**—the presence of stones in the common bile duct—is generally not considered a direct independent risk factor for cholangiocarcinoma. In contrast, **Hepatolithiasis (Option A)**, or intrahepatic stones, is a well-established risk factor due to the chronic recurrent pyogenic cholangitis and mucosal irritation it causes. *Note: There appears to be a discrepancy in the provided key; medically, Choledocholithiasis is the least associated, while Hepatolithiasis is a major risk factor.* **Analysis of Options:** * **Hepatolithiasis (A):** Strongly associated with intrahepatic cholangiocarcinoma, particularly in East Asia, due to chronic biliary stasis and infection. * **Hepatitis C (B):** Recent studies and high-yield texts now recognize HCV (and HBV) as significant risk factors for intrahepatic cholangiocarcinoma, likely due to chronic liver inflammation and cirrhosis. * **Clonorchis sinensis (C):** This liver fluke is a classic "textbook" risk factor. It causes chronic biliary inflammation and hyperplasia, leading to malignancy. * **Choledocholithiasis (D):** While it causes acute biliary issues, simple stones in the CBD do not carry the same oncogenic risk as primary sclerosing cholangitis or fluke infestations. **Clinical Pearls for NEET-PG:** * **Most common risk factor (West):** Primary Sclerosing Cholangitis (PSC). * **Most common risk factor (East):** Liver flukes (*Clonorchis sinensis, Opisthorchis viverrini*) and Hepatolithiasis. * **Congenital risk factor:** Choledochal cysts (especially Type I and IV). * **Tumor Marker:** CA 19-9 is the most commonly used marker for monitoring. * **Klatskin Tumor:** A hilar cholangiocarcinoma occurring at the confluence of the right and left hepatic ducts.
Explanation: ### **Explanation** **1. Why Option A is the Correct (False) Statement:** While conservative surgeries (like deroofing or PAIR) are more common, **hepatic resection (formal lobectomy or segmentectomy) is a recognized surgical option.** It is specifically indicated for large, multiple cysts confined to one lobe, cysts with significant parenchymal destruction, or those located peripherally where resection is safer than evacuation. Therefore, stating it is "never performed" is medically incorrect. **2. Analysis of Incorrect Options (True Statements):** * **Option B:** Laparoscopic aspiration and drainage (often using specialized systems like the Palanivelu hydatid trocar) are standard minimally invasive approaches for uncomplicated cysts. * **Option C:** The **right lobe** is the most common site (approx. 75-80%) because it receives the bulk of portal blood flow, which carries the *Echinococcus granulosus* oncospheres from the intestine. * **Option D:** Most hydatid cysts are **asymptomatic** and are discovered incidentally on imaging. Symptoms (pain, jaundice, or anaphylaxis) usually only occur if the cyst grows large enough to cause pressure or ruptures. ### **Clinical Pearls for NEET-PG:** * **Causative Agent:** *Echinococcus granulosus* (Dog is the definitive host; Human is the accidental intermediate host). * **Imaging Gold Standard:** Ultrasound (Gharbi Classification) is the first-line investigation. Look for the "Water-lily sign" (detached endocyst). * **Medical Management:** **Albendazole** is the drug of choice, started pre-operatively to reduce cyst tension and prevent secondary hydatidosis. * **PAIR Technique:** Puncture, Aspiration, Injection (of scolicidal agents like 20% hypertonic saline or 95% ethanol), and Re-aspiration. **Contraindicated** in cysts communicating with the biliary tree.
Explanation: **Explanation:** **Mirizzi Syndrome** is a rare complication of chronic gallstone disease where a stone impacted in the cystic duct or gallbladder neck causes extrinsic compression of the Common Hepatic Duct (CHD), leading to obstructive jaundice. **Why ERCP is the Correct Answer:** While Ultrasound is often the initial investigation, **ERCP is considered the gold standard for screening and diagnosis** of Mirizzi Syndrome. It provides the highest sensitivity for demonstrating the characteristic features: 1. Extrinsic compression of the CHD. 2. Dilation of the biliary tree proximal to the site of obstruction. 3. Presence of a cholecystobiliary fistula (essential for Csendes classification). Furthermore, ERCP offers therapeutic benefits, such as biliary stenting to decompress the system before definitive surgery. **Why Other Options are Incorrect:** * **Ultrasound Abdomen:** This is the initial investigation of choice. It may show a stone at the gallbladder neck and proximal ductal dilation, but it often fails to differentiate Mirizzi syndrome from other causes of obstructive jaundice or visualize a fistula. * **CECT Abdomen:** Useful for ruling out malignancy (like cholangiocarcinoma), but it lacks the spatial resolution of the biliary tree provided by ERCP or MRCP. * **Plain X-Ray:** Most gallstones are radiolucent (85%); therefore, X-rays have no significant role in the diagnosis of Mirizzi syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Csendes Classification:** Type I (Simple compression), Type II-IV (Fistula involving <1/3, 2/3, or >2/3 of CHD circumference), Type V (Any type + cholecystoenteric fistula). * **Management:** Type I usually requires partial cholecystectomy; Types II-IV often require bilioenteric anastomosis (Roux-en-Y Hepaticojejunostomy). * **MRCP:** Often considered the best *non-invasive* diagnostic tool, but ERCP remains the traditional gold standard in exam contexts due to its diagnostic and therapeutic dual role.
Explanation: **Explanation:** Choledochal cysts are congenital cystic dilatations of the biliary tree. The management of these cysts has evolved significantly, shifting from simple drainage to complete surgical excision. **1. Why "Excision is the ideal treatment" is correct:** The gold standard treatment for most choledochal cysts (specifically Types I, II, and IV) is **complete surgical excision** of the cyst followed by biliary reconstruction, typically via a **Roux-en-Y Hepaticojejunostomy**. The primary reason for excision is the high risk of **cholangiocarcinoma** (malignancy) arising from the cyst wall due to chronic inflammation and the reflux of pancreatic enzymes into the biliary tree (associated with an anomalous pancreaticobiliary ductal junction). **2. Why the other options are incorrect:** * **Option A:** Choledochal cysts are **not always extrahepatic**. While Type I is the most common and is extrahepatic, **Type IV-A** involves both intrahepatic and extrahepatic ducts, and **Type V (Caroli’s Disease)** is purely intrahepatic. * **Options B & D:** Internal drainage (Cystojejunostomy) or external drainage are no longer the treatments of choice. Leaving the cyst wall intact maintains the risk of **malignancy, stone formation, and recurrent cholangitis**. Drainage is only considered a temporary palliative measure in extremely unstable patients. **High-Yield Clinical Pearls for NEET-PG:** * **Todani Classification:** Type I (Saccular/Fusiform dilatation of CBD) is the most common (80-90%). Type III is a Choledochocele. * **Classic Triad:** Jaundice, right upper quadrant pain, and a palpable mass (present in only ~20% of cases, mostly in children). * **Investigation of Choice:** MRCP (Magnetic Resonance Cholangiopancreatography). * **Complication:** The risk of adenocarcinoma increases with age; hence, early prophylactic excision is mandatory.
Explanation: **Explanation:** The development of Gallbladder Carcinoma (GBC) is typically a slow process involving chronic inflammation and mucosal changes. To identify the correct answer, one must distinguish between conditions that cause chronic irritation/dysplasia and those that cause acute or transient biliary issues. **Why Biliary Ascariasis is the correct answer:** While *Ascaris lumbricoides* can migrate into the biliary tract causing biliary colic, cholecystitis, or cholangitis, it is **not** established as a precancerous lesion. Unlike certain liver flukes (e.g., *Clonorchis sinensis*), which are strongly associated with cholangiocarcinoma, biliary ascariasis does not induce the chronic dysplastic mucosal changes required for gallbladder malignancy. **Analysis of Incorrect Options:** * **Porcelain Gallbladder:** This refers to intramural calcification of the gallbladder wall. Historically, the risk was thought to be as high as 25%, but recent studies suggest a lower risk (approx. 7%). However, it remains a classic high-yield precancerous association in surgical textbooks. * **Typhoid Carrier State:** Chronic carriers of *Salmonella typhi* (who harbor the bacteria in the gallbladder) have an 8 to 12-fold increased risk of GBC due to chronic inflammation and the production of carcinogenic metabolites by the bacteria. * **Adenomatous Hyperplasia:** Gallbladder polyps, specifically adenomas, follow the adenoma-carcinoma sequence. Lesions >10mm or those showing sessile growth/hyperplasia carry a significant malignant potential. **NEET-PG High-Yield Pearls:** * **Most common risk factor for GBC:** Cholelithiasis (Gallstones), especially stones >3 cm. * **Anomalous Pancreaticobiliary Duct Junction (APBDJ):** A major risk factor where pancreatic juice refluxes into the GB, causing mucosal dysplasia. * **Mirizzi Syndrome:** Also associated with an increased risk of GBC. * **Epidemiology:** GBC is most common in North Indian females (Gangetic belt).
Explanation: **Explanation:** The correct answer is **B**, as the statement "Surgery should be performed on most cases" is false. **1. Why Option B is the Correct Answer (False Statement):** The management of gallstones (cholelithiasis) is primarily guided by the presence of symptoms. Approximately **80% of patients with gallstones are asymptomatic** ("silent stones"). Current surgical guidelines (SAGES/IHPBA) recommend **expectant management (observation)** for asymptomatic gallstones, as the risk of developing complications is only 1-2% per year. Prophylactic cholecystectomy is only indicated in specific high-risk scenarios (e.g., porcelain gallbladder, stones >3cm, or patients undergoing bariatric surgery). **2. Analysis of Other Options:** * **Option A (True):** Common Bile Duct (CBD) stones (choledocholithiasis) carry a high risk of life-threatening complications like **ascending cholangitis** and **acute pancreatitis**. Therefore, they must be cleared (via ERCP or surgery) regardless of the duct diameter or symptoms. * **Option C (True):** Parasitic infestations, particularly ***Clonorchis sinensis*** (Oriental liver fluke) and ***Ascaris lumbricoides***, can cause biliary stasis and act as a nidus for stone formation (typically primary brown pigment stones). * **Option D (True):** Obstruction of the cystic duct by a gallstone is the primary pathophysiology behind **acute cholecystitis**. **Clinical Pearls for NEET-PG:** * **Gold Standard Investigation:** Ultrasonography (USG) of the abdomen (high sensitivity/specificity). * **Most Common Type:** Cholesterol stones (Western world); however, mixed stones are very common globally. * **Risk Factors (The 5 F's):** Fat, Female, Fertile, Forty, Fair. * **Saint’s Triad:** Cholelithiasis, Hiatus hernia, and Diverticulosis.
Liver Anatomy and Physiology
Practice Questions
Benign Liver Lesions
Practice Questions
Liver Abscess
Practice Questions
Hepatocellular Carcinoma
Practice Questions
Metastatic Liver Disease
Practice Questions
Cirrhosis and Portal Hypertension
Practice Questions
Liver Trauma
Practice Questions
Cholelithiasis and Cholecystitis
Practice Questions
Choledocholithiasis
Practice Questions
Biliary Tract Tumors
Practice Questions
ERCP and Its Complications
Practice Questions
Liver Transplantation Basics
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free